Rajesh Karan

Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis

Bruce Cree, Myla Goldman, John R. Corboy et al. · JAMA Neurology · 2020 · 44 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +7

Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression.

Vaya Lalit, P Appaya, Rajendra P Hegde et al. · PubMed · 2004 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension

Prafulla Bhad, Surya Ayalasomayajula, Rajesh Karan et al. · The Journal of Clinical Pharmacology · 2010 · 23 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIG<i>MS</i> Study

Lauren Krupp, Brenda Banwell, Tanuja Chitnis et al. · BMJ Neurology Open · 2022 · 17 citations · Full text

Medicine, Neurology, Pediatric Neurology +3

Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG <i>MS</i> study

Tanuja Chitnis, Brenda Banwell, Lauren Krupp et al. · Multiple Sclerosis Journal · 2020 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +13